Human IL-4 ELISA Kit
Cat.No:SEKH-0011 Solarbio
Application:ELISA
Reactivity:Human
Sample Type:Serum,Plasma,Cell Culture Supernatant
Sensitivity:2 pg/ml
Storage:2-8℃,6 months
Gene ID:3565
Qty:
Size:
{{cart_num}}
My CartApplication:ELISA
Reactivity:Human
Sample Type:Serum,Plasma,Cell Culture Supernatant
Sensitivity:2 pg/ml
Storage:2-8℃,6 months
Gene ID:3565
Qty:
Size:
Name | Human IL-4 ELISA Kit |
Storage | 2-8℃,6 months |
Detection Target | IL-4 |
Sample Type | Serum,Plasma,Cell Culture Supernatant |
Reactivity | Human |
Application | ELISA |
Reaction Type | Sandwich-ELISA |
Quantitative/Qualitative | Quantitative |
Detection Range | 3.12-200 pg/ml |
Sensitivity | 2 pg/ml |
Specificity | Do not react with Human IL-3, Human IL-4Rα, Human IL-5, Human IL-13, Mouse IL-3, Mouse IL-4, Mouse IL-4Rα,牛IL-4,犬IL-4 etc. |
Precision | Both intra-plate and inter-plate variation coefficients were less than 10% |
Recovery | 80%-120% |
Assay Time | 3h |
Swiss Prot | P05112 |
Gene ID | 3565 |
Detection Principle | Solarbio ELISA试剂盒采用基于双抗体夹心法的酶联免疫吸附检测技术。将抗人IL-4单克隆抗体包被在酶标板上;分别加入梯度稀释的标准品和预稀释的样本,标准品和样本中的人IL-4会与酶标板上的包被抗体充分结合;洗板后加入生物素化抗人IL-4抗体,该抗体会与板子上包被抗体捕获的标准品和样本中的人IL-4发生特异性结合;洗板后加入辣根过氧化物酶(HRP)标记的链霉亲和素,生物素与链霉亲和素会发生高强度的非共价结合;洗板后加入显色剂底物TMB,若反应孔中样品存在不同浓度的人IL-4,则HRP会使无色TMB变成不同深浅(正相关)的蓝色物质,加入终止液后反应孔会变成黄色;最后,在λmax=450 nm(OD=450 nm)处测定反应孔样品吸光度(OD),样本中的人IL-4浓度与OD成正比,通过绘制标准曲线和四参数拟合软件便可计算出样本中人IL-4的浓度。 |
Unit | Kit |
Specification | 48T 96T |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no experimental images.
Sorry, there is no more information.
Contriving a novel of CHB therapeutic vaccine based on IgV_CTLA-4 and L protein via immunoinformatics approach
Click to check >>Author:Yuejie Zhu, Mingkai Yu, Maierhaba· Aisikaer, Chuntao Zhang, Yueyue He, Zhiqiang Chen, Yinyin Yang, Rui Han, Zhiwei Li, Fengbo Zhang, Jianbing Ding, Xiaobo Lu
IF:4.4000
Publish_to:JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
PMID:37424209